Financials
- Market Capitalization 165.08 M
- Employee 36
- Founded 2009
- CEO N/A
- Website www.corbuspharma.com
- Headquarter Delaware, United States
- FIGI BBG0078PJKQ7
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.64
Relación precio/flujo de caja
24.01
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3734 | ADAG Adagene Inc - ADS, each representing 1.25 | 3.64 USD | +0.83% | -7.38% | +2.25% | +105.65% | 172.48 M USD | ||
| 3736 | IPHA Innate Pharma S.A. - American Depositary Shares | 1.80 USD | -1.10% | -2.17% | -2.17% | 0.00% | 168.69 M USD | ||
| 3745 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.59 USD | -3.57% | +3.38% | -6.90% | +333.02% | 165.31 M USD | ||
| 3748 | ALEC Alector, Inc. - Common Stock | 1.50 USD | +7.91% | -18.48% | +2.04% | -5.66% | 166.54 M USD |